MARKET

AVCO

AVCO

AVALON GLOBOCARE
NASDAQ

Real-time Quotes | Nasdaq Last Sale

1.738
-0.012
-0.70%
Opening 12:31 07/13 EDT
OPEN
1.760
PREV CLOSE
1.750
HIGH
1.840
LOW
1.720
VOLUME
396.27K
TURNOVER
--
52 WEEK HIGH
2.650
52 WEEK LOW
0.5000
MARKET CAP
137.92M
P/E (TTM)
-7.7789
1D
5D
1M
3M
1Y
5Y

AVCO News

More
Here's What Avalon GloboCare Corp.'s (NASDAQ:AVCO) Shareholder Ownership Structure Looks Like
Simply Wall St. · 07/03 19:37
Avalon GloboCare's CAR-T therapy completes early-stage study in B-cell malignancies
Seeking Alpha - Article · 06/29 17:44
Avalon GloboCare Announces Successful Completion of Phase I Clinical Study of CAR T-Cell Therapy Candidate AVA-001
GlobeNewswire · 06/29 14:30
Avalon GloboCare Announces Successful Completion of Phase I Clinical Study of CAR T-Cell Therapy Candidate AVA-001
- Completed Phase I Clinical Study of 4-1BB Based Anti-CD19 CAR-T Therapy for Relapsed/Refractory B-Cell Acute Lymphoblastic Leukemia   - Achieved 90% Complete Remission (CR) Rate with Minimum Toxicity or
Completed Phase I Clinical Study of 4-1BB Based Anti-CD19 CAR-T Therapy for Relapsed/Refractory B-Cell Acute Lymphoblastic Leukemia   - Achieved 90% Complete Remission (CR) Rate with Minimum Toxicity or · 06/29 13:33
Avalon GloboCare +7% on partnership with University of Natural Resources and Life Sciences
Seeking Alpha - Article · 06/25 16:55
Avalon GloboCare Achieves Milestones in Advancing Novel Intranasal and Oral COVID-19 Vaccine Candidate
GlobeNewswire · 06/25 14:00
Eminent Member of the Austrian Academy of Sciences, Professor Uwe B. Sleytr, Joins Avalon GloboCare's Scientific and Clinical Advisory Board
GlobeNewswire · 06/16 14:00
Avalon GloboCare Announces Three-Way Material Transfer Agreement with Weill Cornell Medicine and Arbele Limited for Development of Next Generation Cellular Immunotherapy FLASH-CAR Technology
GlobeNewswire · 06/11 14:00

Industry

Biotechnology & Medical Research
+1.58%
Pharmaceuticals & Medical Research
+1.71%

Hot Stocks

Symbol
Price
%Change

About AVCO

Avalon GloboCare Corp. is an intelligent biotech developer and healthcare service provider. The Company engages in the management of stem cell banks and specialty clinical laboratories. It is developing of exosome technology to improve the diagnosis and management of diseases. The Company operates through two platforms, Avalon Cell and Avalon Rehab. Its technology and service ecosystem covers the areas of regenerative medicine, cell-based immunotherapy, exosome technology, as well as rehabilitation medicine. The Company also focused on diagnostic advancements in the fields of oncology, infectious diseases and fibrotic diseases, and the discovery of disease-specific exosomes to provide the disease origin insight necessary to enable.
More

Webull offers kinds of Avalon Globocare Corp stock information, including NASDAQ:AVCO real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, AVCO stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading AVCO stock methods without spending real money on the virtual paper trading platform.